Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03455556
Title Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mayo Clinic

lung non-small cell carcinoma


Anetumab ravtansine + Atezolizumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.